AzurRx BioPharma, Inc.
AZRX · NASDAQ
12/31/2024 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $163 | $6 | $176 | $1,114 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $2,637 | $3,173 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $83,315 | $2 | $595 | $513 |
| Total Curr. Assets | $83,479 | $8 | $3,408 | $4,800 |
| Property Plant & Equip (Net) | $127 | $0 | $160 | $129 |
| Goodwill | $1,684 | $2 | $1,887 | $1,925 |
| Intangibles | $0 | $0 | $3,407 | $570 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $120 | $0 | $41 | $45 |
| Total NC Assets | $1,931 | $2 | $5,495 | $2,669 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $85,410 | $10 | $8,903 | $7,469 |
| Liabilities | – | – | – | – |
| Payables | $2,959 | $2 | $2,217 | $2,202 |
| Short-Term Debt | $82 | $610 | $1,605 | $255 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | -$0 | $0 | $0 |
| Other Curr. Liab. | $24,505 | -$596 | $464 | $538 |
| Total Curr. Liab. | $27,546 | $16 | $4,286 | $2,996 |
| LT Debt | $59 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $59 | $0 | $0 | $0 |
| Other Liabilities | $0 | -$0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $27,605 | $16 | $4,286 | $2,996 |
| Equity | – | – | – | – |
| Pref Stock | $61,681 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $3 | $2 |
| Retained Earnings | -$202,388 | $0 | -$62,695 | -$47,517 |
| AOCI | $0 | -$1,113 | -$1,267 | -$1,150 |
| Other Equity | $198,511 | -$1,528 | $68,576 | $53,139 |
| Total Equity | -$3,877 | -$2,641 | $4,617 | $4,474 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $85,410 | $10 | $8,903 | $7,469 |
| Net Debt | -$23 | $604 | $1,429 | -$859 |